Healthpeak Pays September Dividend as Healthcare Real Estate Outlook Improves
Healthpeak Properties is sending another monthly dividend to shareholders Friday, putting the healthcare real estate investment trust back on investors' radar as it works through an improving operating environment and a stronger 2026 outlook.
Shareholders of DOC who were eligible for the September distribution are receiving $0.10167 per share on September 25. The payment follows identical monthly distributions in July and August.
The three payments total $0.305 per share for the third quarter. At the current rate, Healthpeak's dividend amounts to approximately $1.22 per share annually, giving the stock a yield of roughly 6% at recent prices.
Healthpeak differs from many traditional real estate companies because its portfolio is concentrated on properties connected to healthcare delivery and scientific research. The company owns medical office buildings, outpatient facilities and laboratory properties serving healthcare systems and life-science organizations.
That focus gives DOC exposure to long-term healthcare demand while still leaving the company sensitive to interest rates, borrowing costs, property valuations and development activity.
The shares recently traded around $20.50 after climbing substantially from their lows of the past year. The stock has gained more than 30% since the beginning of 2026, although it remains below its 52-week high above $22.
Healthpeak's latest operating results provided investors with some additional reasons for optimism. The company increased its full-year 2026 earnings guidance after reporting its second-quarter results in August.
Management now expects diluted earnings per share of approximately $0.48 to $0.52 for the full year, compared with its previous range of $0.46 to $0.50. The midpoint of the forecast therefore increased by two cents per share.
Healthpeak also raised its outlook for adjusted funds from operations, a closely watched measure for real estate investment trusts. The company now expects adjusted FFO of $1.73 to $1.77 per share, up from its earlier projection of $1.71 to $1.75.
Another encouraging development for DOC has been the company's improved expectations for its existing properties. Healthpeak increased the midpoint of its forecast for same-store cash adjusted net operating income, indicating better anticipated performance from properties already in the portfolio.
The combination of an improving operating outlook and a substantial dividend yield has helped make Healthpeak more sensitive to changes in interest-rate expectations. Real estate investment trusts often become more attractive to income-oriented investors when bond yields decline because their dividend yields become comparatively more competitive.
Lower borrowing costs can also benefit companies such as Healthpeak directly. REITs frequently use debt to finance acquisitions, developments and property improvements, making the cost of capital an important factor in determining future returns.
The company's healthcare focus provides another potential advantage. Demand for medical services is generally less economically sensitive than demand for many other forms of commercial real estate, while an aging U.S. population continues to increase utilization of outpatient and other healthcare services.
Life-science properties present a more complicated picture. Research laboratories and biotechnology facilities experienced rapid expansion earlier in the decade, followed by a slowdown as biotechnology financing weakened and new property supply entered several major markets. Healthpeak must therefore balance stronger healthcare-property fundamentals against a still-evolving life-science environment.
Investors are also paying attention to short interest in DOC. Roughly 24 million shares have recently been sold short, representing approximately 3.5% of the available share float. That figure has increased considerably during the past year despite the stock's improving performance.
With a market capitalization of roughly $14 billion, Healthpeak sits toward the smaller end of the S&P 500. Its combination of healthcare exposure, monthly dividends and sensitivity to interest rates gives the shares a substantially different investment profile from many of the technology and consumer companies that dominate the index.
Friday's dividend payment does not change the company's underlying valuation, but it highlights a central part of the investment case for DOC. Investors are being paid monthly while waiting to see whether improved property performance, easing financing conditions and rising healthcare demand can support additional growth.
